Biogen claims victory in patent dispute with Mylan over MS d...

Alexion’s biosimilar-blocking EU patent play for Soliris fai...

Celgene gets US patent let-off ahead of BMS merger

Shares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on its multi-billion dollar cancer drug Revlimid, a decision that could ease shareholder ten

Indivior hit hard as generic Suboxone defence crumbles

Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.

Pfizer hit by UK Supreme Court ruling on Lyrica patent

Pfizer has lost its protracted patent battle in the UK for big-selling drug Lyrica, potentially exposing it to claims for hundreds of millions of pounds from the NHS.

Biogen gets go-ahead for EU Humira launch in October

But deal with Samsung prevents US launch until mid-2023